24 February 2026

Trade of The Day

Toku Ltd (SGX: TKU)

Analyst: Zane Aw

Current Price: S$0.260) – TECHNICAL BUY
Buy price: S$0.260 Stop loss: S$0.230 (-11.53%)
Take profit: S$0.305 (+17.30%)

Factsheets


Trades Initiated in Past Week

Factsheets


UOB’s 4Q25 earnings of S$1,410mn were slightly below our estimates, with FY25 earnings at 98% of our FY25e forecast. NII fell 4% YoY to S$2,346mn as loan growth of 4% YoY cushioned NIM decline of 16bps to 1.84%. Fee income grew 10% YoY from broad based growth. Allowances fell by 50% YoY to S$113mn from lower SPs. Resultantly, total credit costs fell 6bps YoY to 19bps. Final dividend declined 23% YoY to 71cents with FY25 dividends at S$1.81 including the 25cents capital return dividend (FY24: S$2.05 including 25cent capital return dividend), dividend payout ratio was kept at 50%. They provided FY26e guidance for NIM of 1.75-1.80%, low single digit loan growth, high single digit fee income growth and credit costs at around 25-30bps.

Glenn Thum
Research Manager
glennthumjc@phillip.com.sg


Singapore stocks ended higher on Monday (Feb 23) as investors processed the news of US President Donald Trump’s latest global tariffs announced over the weekend. The local benchmark gained 0.5% or 23.73 points to finish at 5,041.33. Meanwhile, the iEdge Singapore Next 50 Index remained almost flat at 1,520.5.

U.S. equities tumbled on Monday as investors grappled with persistent fears around artificial intelligence disruptions to various industries and President Donald Trump’s decision to raise his global tariffs. The Dow Jones Industrial Average dropped 821.91 points, or 1.66%, to close at 48,804.06, while the Nasdaq Composite declined 1.13% and ended at 22,627.27. The S&P 500 shed 1.04% and closed at 6,837.75, putting it into the red once again for 2026.


Singapore Technical Highlights

Factsheets


TOP 5 GAINERS & LOSERS

Factsheets


Events Of The Week

Factsheets


SG

Raffles Medical Group posted a 21.7% rise in net profit to S$38.5 million for its second half ended Dec 31, 2025, from S$31.6 million for the previous corresponding period. This was mainly due to improved performance from its hospital services and insurance businesses, as well as fair value gains on investment properties.

Centurion Accommodation Reit posts DPU of S$0.01739 in first results since IPO. Revenue was at S$50.7 million for the period from Sep 24 to Dec 31, 3.4% higher than its S$49 million forecast. This was primarily from higher rental rates in Singapore, as well as better-than-expected occupancy rates in its portfolio.

ValueMax on Monday (Feb 23) posted a 14% increase in net profit to S$54.1 million for the six months ended Dec 31, 2025, from S$47.4 million in the same period a year earlier. This came on the back of a 25.8% rise in revenue to S$284.8 million, from S$226.4 million previously. The increase is mainly due to increases in cost of sales for retail and trading of jewellery and gold and moneylending businesses of S$39.2 million and S$300,000, respectively.

MoneyMax Financial Services reported that its profit for the second half of 2025 nearly doubled to S$42 million, from S$21.6 million the year before, on the back of strong growth in its core business segments. This was achieved amid strong business fundamentals and a record performance for the full year.

CapitaLand Ascott Trust on Monday (Feb 23) announced the acquisition of three freehold rental housing properties in Southern Kanagawa, Greater Tokyo, for 4.6 billion yen (S$38.3 million) from an unrelated third party, Patience Capital Group. The assets have an average occupancy of more than 95% and average lease terms of about two years, providing stable income.

Seatrium expects to achieve over S$50 million in annualised operational cost savings by early 2026 through the divestment of non-core assets. The savings follow a series of transactions involving shipyards, tugboats and equipment across Singapore and Indonesia.

Great Eastern Holdings’s FY2025 profit attributable to shareholders rose by 21% year on year to $1,207.1 million. Net profit in 4Q2025 rose by 70% year on year underpinned by a favourable investment performance and earnings from the existing in-force portfolio.


US

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. The pen could serve as a more convenient option for some patients, as it reduces the number of devices they have to use in a month to take the drug. Prices start at $299 for the lowest dose level on Eli Lilly’s direct-to-consumer site, LillyDirect.

Johnson Matthey cut the price of its catalyst technologies unit sale to Honeywell International by over a quarter. The unit will now sell for 1.325 billion pounds, with the deal deadline extended to July 21. The lower price reflects the unit’s fiscal 2026 performance and a challenging market environment.

PayPal Holdings, the digital payments pioneer, is attracting takeover interest from potential buyers after a stock slide wiped out almost half of its value. The shares jumped as much as 9.7% on the news. The San Jose, California-based company has fielded meetings with banks amid unsolicited interest from suitors.

Paramount Skydance Corp. raised its offer to buy Warner Bros. Discovery Inc., extending the battle for the iconic studio. The new bid improves on the $30-a-share proposal and addresses concerns including greater certainty of Paramount financing. Warner Bros. will consider the new Paramount offer and if deemed superior, Netflix will have four days to respond.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, The Edge Singapore, PSR


RESEARCH REPORTS


Market Journal articles powered by PhillipGPT

Singapore Budget 2026 Signals Strategic AI Pivot, Equity Boost

DBS Group Holdings Ltd Upgraded to Accumulate Despite Earnings Decline

Elite UK REIT Shows Strong Performance with Successful Lease Regearing


PSR Stocks Coverage

Factsheets


For more information, please visit:

https://www.stocksbnb.com/singapore-stocks-coverage/


Upcoming Webinars

Corporate Insights by Stoneweg Europe Stapled Trust (SERT)

Date & Time: 27 February 26 | 12PM-1PM

Register: poems-20260227-138685


Corporate Insights by Attika Group [NEW]

Date & Time: 3 March 26 | 12PM-1PM

Register: poems-20260303-139953


Corporate Insights by LMS Compliance [NEW]

Date & Time: 4 March 26 | 12PM-1PM

Register: poems-20260304-139955


Corporate Insights by OUE REIT

Date & Time: 5 March 26 | 12PM-1PM

Register: poems-20260212-138119


Corporate Insights by Lendlease REIT

Date & Time: 10 March 26 | 12:30PM-1:30PM

Register: poems-20260310-138683


POEMS Podcast:

Research Videos

Weekly Market Outlook: ABNB, Reddit, SPOT, Grab, DBS, LREIT, CLI, TMG, Mag7, SG Weekly & More!
Date: 23 Feb 2026

Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.

PHILLIP RESEARCH IN 3 MINS

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com